Soteria Biotherapeutics
PrivateLast Round
Series A
May 17, 2021
Total Funding Raised
$42.3M
Company Overview
Soteria Biotherapeutics operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in May 2021.
Soteria Biotherapeutics is a biotechnology company developing switchable bispecific T-cell engagers designed to treat cancer patients with solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Soteria Biotherapeutics Comparables
Compare Soteria Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bonum Therapeutics | 92% | |
| Tentarix Biotherapeutics | 80% | |
| CytomX Therapeutics | 79% |
For institutional investors. Book with your work email.
Soteria Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 17, 2021 | ||||
| Grant | Apr 1, 2019 |
For institutional investors. Book with your work email.
Soteria Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Roche Venture Fund | Series A |
| NIH RADx | Grant |
| M Ventures | Series A |
| 5AM Ventures | Series A |
| Roche Venture Fund | Series A |
| Alexandria Venture Investments | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 9, 2025
Monthly visitors grew 36% MoM, from 590 to 800.
- May 17, 2021
$42M round led by Roche Venture Fund and 5AM Ventures.
For institutional investors. Book with your work email.
Soteria Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Soteria Biotherapeutics's valuation, stock price, and market status.
Is Soteria Biotherapeutics a public or private company?
Soteria Biotherapeutics is a private company.
What is the current stock price of Soteria Biotherapeutics?
Soteria Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks Soteria Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Soteria Biotherapeutics worth (valuation)?
Valuation information for Soteria Biotherapeutics is not publicly available.
Can I buy Soteria Biotherapeutics stock?
Soteria Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Soteria Biotherapeutics's last funding round?
Soteria Biotherapeutics's most recent funding round was Series A on May 17, 2021.
Who are the main investors in Soteria Biotherapeutics?
Key investors in Soteria Biotherapeutics include Roche Venture Fund, 5AM Ventures, Roche Venture Fund.
Will Soteria Biotherapeutics IPO soon?
No public IPO plans have been announced for Soteria Biotherapeutics.
How can I track Soteria Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Soteria Biotherapeutics's shares on secondary markets.